The only partners listed on ANI website are Teva and Aduro.
Begs to question what about Elestrin and Meda agreeement.
In fairness Pryzbyl has stated in the past he brings to light immediate revenue generators only, focusing in the present Elestrin milestone payments may be too far off for him to include in the filing.
On the other hand you have to wonder, is the women's division being sold?
They know we have been watching and researching their moves and continue to do so. This will persist until the trust in the new management has been reestablished (still a long way to go). In the meantime I continue to build a case I hope, we will never have to use.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.